KCM
MRK icon

Kingdon Capital Management’s Merck MRK Stock Holding History

Kingdon Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-358,206
Closed -$28.4M – 68
2020
Q3 		$28.4M Buy
+358,206
New +$28.1M 3.18% 8
2013
Q3 		– Sell
-66,234
Closed -$2.94M – 211
2013
Q2 		$2.94M Buy
+66,234
New +$2.96M 0.17% 144

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Kingdon Capital Management's MRK Position: Q4 2020 in Review

Kingdon Capital Management sold out of Merck (MRK) in Q4 2020, closing a stake of 358,206 shares — an estimated $28.4M sold.

Kingdon Capital Management first reported a position in MRK in Q2 2013 and held it in 2 quarters. The position peaked at $28.4M in Q3 2020. 2,710 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Kingdon Capital Management reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Kingdon Capital Management sold 358,206 Merck shares in Q4 2020, an estimated $28.4M.
  • Kingdon Capital Management first reported a position in Merck in Q2 2013 and held it in 2 quarters.
  • Kingdon Capital Management's Merck position peaked at $28.4M in Q3 2020.
  • 2,710 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Kingdon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.